Innovative Technology New Health Sciences focuses on developing advanced blood storage solutions with potential to extend shelf life and improve transfusion safety, offering a unique value proposition for healthcare providers and blood banks seeking cutting-edge blood management technologies.

Market Growth Potential With a revenue estimate between one and ten million dollars and ongoing development funded by NIH grants and private investors, there is significant growth opportunity aligned with increasing demand for innovative medical equipment in transfusion therapies.

Partnership Opportunities Collaborating with research institutions or medical device manufacturers could accelerate the commercialization of Hemanext technology, creating potential channels for joint ventures or strategic partnerships.

Target Customer Segments Potential clients include hospitals, blood banks, and transfusion clinics seeking improved blood storage solutions, presenting sales pathways through direct outreach, demonstrations, and pilot programs.

Competitive Advantage By emphasizing the proprietary nature of its storage technology and NIH-backed research, New Health Sciences can position itself as a leader in innovative transfusion safety and quality solutions, appealing to health systems focused on patient safety and operational efficiency.